Guidance in topic selection

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Area of interest

Area of interest

Technology type

Technology type

Topic selection decision

Topic selection decision

Type

Type

Showing 51 to 60 of 345

TitleTechnology typeDecisionDecision date
Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128]MedicineNot selected
Berotralstat for preventing recurrent attacks of hereditary angioedema in children aged 2 to 12 years [TSID 12132]MedicineNot selected
Lebrikizumab for treating atopic dermatitis in children [TSID 12133_TSID 12135]MedicineNot selected
Clindamycin for treating bacterial vaginosis in females aged 12 and older [TSID 12127]MedicineNot selected
Diclofenac–clotrimazole for Vulvovaginal candidiasis (VVC) [TSID 12053]MedicineNot selected
Lebrikizumab for treating atopic dermatitis in children [TSID12133]MedicineNot selected
Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more treatments (review of TA881) [ID6496]MedicineAwaiting decision
Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy (review of TA673) [ID6403]MedicineAwaiting decision
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 therapies (MA review TA704 and TA862) [ID5121]MedicineAwaiting decision
Avatrombopag for treating primary chronic immune thrombocytopenia in people 1 to 17 years [TSID12109]MedicineNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All